FEATURE ARTICLES

Takeda’s New Plans For Worldwide Growth
Takeda’s New Plans For Worldwide Growth

Christophe Weber, the current and still nascent CEO of Takeda, is also an unavoidable symbol of the company’s current transformation into a global organization as the first non-Japanese person to head a Japan-based pharma company.

More featured articles

ALSO IN THIS MONTH'S ISSUE:

  • Who Will Move Biopharma Beyond The Cutting Edge?
    Who Will Move Biopharma Beyond The Cutting Edge?

    Biopharma challenges, such as developing innovative therapeutics at a price and cost we can all afford, might benefit from an outsider’s perspective — especially if we ever hope to push our industry to a point somewhere beyond the cutting edge.

  • Congress Rebukes CMS On Part B Demo
    Congress Rebukes CMS On Part B Demo

    CMS has received dramatic and overwhelming rejection from Congress and stakeholders demanding the proposal be withdrawn or substantially modified.

  • In A Political Year, We Need To Remember The Value Of Pharma/Bio
    In A Political Year, We Need To Remember The Value Of Pharma/Bio

    The drug pricing debate has been particularly challenging for our industry, and, with the presidential election coming up, I can’t help feeling that the attacks will only get worse.

  • How Agile Therapeutics Got Through A Critical Phase 3 Trial
    How Agile Therapeutics Got Through A Critical Phase 3 Trial

    The challenges of conducting a Phase 3 trial and then using that data to get an approval from the FDA are something every head of clinical research knows very well. Agile Therapeutics hired Elizabeth Garner as chief medical officer and SVP of clinical development to take control of the process.

  • Alios BioPharma: From Startup To Big Pharma
    Alios BioPharma: From Startup To Big Pharma

    If you had told Lawrence Blatt a decade ago that he and his team from then-fledging startup Alios BioPharma would today be working under the Big Pharma umbrella of Johnson & Johnson, he’d likely have written you off as delusional.

  • Pharma Scientist Paves His Own Corporate Path
    Pharma Scientist Paves His Own Corporate Path

    “It was a little frustrating for me, because you feel like your ideas and IP are tied up in the company.It did slow me down for a few years, and I was not able to regain control of that IP until 2006.”

More from Life Science Leader

CUTTING ROOM FLOOR EDITORIAL

More cutting room floor editorial

WEB-EXCLUSIVE EDITORIAL

More web-exclusive editorial

LIFE SCIENCE TRAINING INSTITUTE COURSES

Best Practices in CMC Dossier Preparation – Facing Tough Challenges July 28, 2016
Special Time for EU and US Participants - 10:30am-12pm EDT, Online Training
More training courses

JUNE 2016 DIGITAL EDITION

2016 CRO AWARDS SPECIAL EDITION

2016 CMO AWARDS SPECIAL EDITION

BLOGS

  • BIO Still Delivers
    BIO Still Delivers

    If the BIO International Convention did nothing but assemble the 16,000 people who came to this year’s meeting in San Francisco, simply giving them a space to talk, that alone would be a great achievement.

  • Is BIO’s Annual Meeting Too Big?
    Is BIO’s Annual Meeting Too Big?

    As a past BIO educational planning committee co-chair, I am well aware of the amount of effort that goes into the successful planning one of our industry’s biggest gatherings — BIO International’s Annual Convention. Typically drawing more than 15,000 attendees from nearly every U.S. state and over 65 countries, this year’s event took place June 6 – 9 at the Moscone Center in San Francisco. And while I have always been a big fan of BIO, this year’s event made me wonder: Is BIO too big to be effective? After all, the event boasts having 7 product zones, 18 educational tracks, 6 super sessions, 2 keynotes, and 3 fireside chats. That doesn’t even include the roughly 4,000 companies represented at the event, 1,800 of which typically exhibit.

More blogs

 UPCOMING EVENTS

DIA 2016 June 26 - 30, 2016
Philadelphia, PA
Melissa Carella June 28 - 29, 2016
Burlington, MA
Effective Batch Record Review - Getting It Right The First Time June 28, 2016
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
More events